Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 22302033)

1.

Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.

Roberts PJ, Bisi JE, Strum JC, Combest AJ, Darr DB, Usary JE, Zamboni WC, Wong KK, Perou CM, Sharpless NE.

J Natl Cancer Inst. 2012 Mar 21;104(6):476-87. doi: 10.1093/jnci/djs002. Epub 2012 Feb 1.

2.

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer.

Rocca A, Farolfi A, Bravaccini S, Schirone A, Amadori D.

Expert Opin Pharmacother. 2014 Feb;15(3):407-20. doi: 10.1517/14656566.2014.870555. Epub 2013 Dec 26. Review.

PMID:
24369047
3.

Molecular pathways: CDK4 inhibitors for cancer therapy.

Dickson MA.

Clin Cancer Res. 2014 Jul 1;20(13):3379-83. doi: 10.1158/1078-0432.CCR-13-1551. Epub 2014 May 2. Review.

4.

Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy.

Migliaccio I, Di Leo A, Malorni L.

Curr Opin Oncol. 2014 Nov;26(6):568-75. doi: 10.1097/CCO.0000000000000129. Review.

PMID:
25188473
5.

Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.

Senderowicz AM.

Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S61-73. Epub 2003 Jun 18. Review.

PMID:
12819936
6.

Cyclin-dependent kinase 4/6 (cdk4/6) inhibitors: perspectives in cancer therapy and imaging.

Graf F, Mosch B, Koehler L, Bergmann R, Wuest F, Pietzsch J.

Mini Rev Med Chem. 2010 Jun;10(6):527-39. Review.

PMID:
20370706
7.

The Role of CDK4/6 Inhibition in Breast Cancer.

Murphy CG, Dickler MN.

Oncologist. 2015 May;20(5):483-90. doi: 10.1634/theoncologist.2014-0443. Epub 2015 Apr 15. Review.

PMID:
25876993
8.

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions.

Witkiewicz AK, Knudsen ES.

Breast Cancer Res. 2014 May 7;16(3):207. doi: 10.1186/bcr3652. Review.

9.

Targeting cell cycle regulators in hematologic malignancies.

Aleem E, Arceci RJ.

Front Cell Dev Biol. 2015 Apr 9;3:16. doi: 10.3389/fcell.2015.00016. eCollection 2015. Review.

10.

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.

Sánchez-Martínez C, Gelbert LM, Lallena MJ, de Dios A.

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3420-35. doi: 10.1016/j.bmcl.2015.05.100. Epub 2015 Jun 6. Review.

PMID:
26115571
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk